Laboratory Cost per Test is a vital KPI that gauges the financial efficiency of lab operations.
It directly impacts profitability, resource allocation, and overall operational efficiency.
By tracking this metric, organizations can identify cost-saving opportunities and streamline processes, ultimately enhancing their financial health.
A lower cost per test indicates effective resource management and can lead to improved ROI metrics.
Conversely, higher costs may signal inefficiencies that need addressing.
Strategic alignment with this KPI helps labs maintain competitiveness in a rapidly evolving healthcare landscape.
Laboratory Cost per Test belongs to the Laboratory Quality Management KPI group, where it ranks thirty-ninth of fifty-one members. That placement marks it as a lower-order, supporting cost metric rather than a headline driver. The group leads with process and compliance metrics: Calibration Schedule Adherence sits first, Test Result Reproducibility Rate second, followed by Laboratory Audit Findings, Regulatory Compliance Rate, Proficiency Testing Performance, Result Accuracy Verification Rate, Laboratory Incident Rate, and Critical Value Reporting Timeliness among the top members. Those are the metrics management watches first, and cost per test reads against them rather than ahead of them.
Its BSC placement is financial, which makes it a lagging efficiency measure: it reports the settled cost of work already performed, so it confirms outcomes rather than predicting them. The internal-perspective co-metrics above it are the leading signals that a rising or falling cost per test will eventually reflect.
The genuine tension is direct. Pushing Laboratory Cost per Test down can pressure the very quality members it sits beside. Trimming reagent grades, deferring calibration, or thinning quality-control runs lowers cost per test on paper while eroding Test Result Reproducibility Rate and Result Accuracy Verification Rate, and it can slow Test Turnaround Time if cheaper batching delays priority assays. Read cost per test alongside those named co-metrics, never in isolation, or a financial win can quietly register as a quality loss elsewhere in the group.
The formula is total costs associated with testing divided by total number of tests performed, so both the numerator and the denominator are choices, not givens. On the cost side, decide up front which inclusions belong: direct labour, reagents and consumables, equipment depreciation, facility and administrative overhead, and send-outs to reference laboratories. A number that counts only reagents and labour is not comparable to one that loads full overhead and depreciation, and mixing the two across periods or sites produces a trend that reflects accounting policy rather than real efficiency.
The denominator forks just as hard. Decide what counts as a test: a billable test, a single analyte, or a multi-analyte panel treated as one. A panel counted as one test versus its component analyte reads very differently, and the choice must be held constant. Volume then drives fixed-cost allocation: depreciation and overhead are largely fixed, so higher throughput spreads them thinner and lowers cost per test even when nothing about the process improved, while a low-volume period inflates it. Segment by test mix so that a shift toward complex, low-volume assays is not misread as a cost problem when it is really a mix change.
The main instrumentation pitfall is allocating shared costs. Analysers, staff, and facilities serve many test types at once, so the rule used to split those shared costs across tests can move cost per test more than any operational change. Fix the allocation basis, document it, and segment by department and complexity, or the metric will drift on allocation choices rather than on the work itself.
Many laboratories overlook the significance of tracking Laboratory Cost per Test, leading to inflated expenses and reduced profitability.
Enhancing Laboratory Cost per Test requires a strategic focus on efficiency and resource management.
We have 4 relevant benchmarks in our benchmarks database.
Source: Subscribers only
Source Excerpt: Subscribers only
Additional Comments: Subscribers only
| Value | Unit | Type | Company Size | Time Period | Population | Industry | Geography | Sample Size |
| Subscribers only | 2018 US$ per test | average; range | 2017–2018 | suspected TB patients; provider perspective | healthcare diagnostics | Ethiopia (Arsi zone) | 1332 patients per intervention |
Source: Subscribers only
Source Excerpt: Subscribers only
Additional Comments: Subscribers only
| Value | Unit | Type | Company Size | Time Period | Population | Industry | Geography | Sample Size |
| Subscribers only | percent | average reduction | report year | pathology tests across networked NHS laboratories | pathology | England |
Source: Subscribers only
Source Excerpt: Subscribers only
Additional Comments: Subscribers only
| Value | Unit | Type | Company Size | Time Period | Population | Industry | Geography | Sample Size |
| Subscribers only | $ per test | average | complex pathology tests | pathology | England; Australia; USA |
Source: Subscribers only
Source Excerpt: Subscribers only
Additional Comments: Subscribers only
| Value | Unit | Type | Company Size | Time Period | Population | Industry | Geography | Sample Size |
| Subscribers only | $ per test | routine chemistry and haematology tests | pathology | USA; UK; Australia |
Browse the Top Benchmarked KPIs in Laboratory Quality Management
The four tracked sources all describe healthcare pathology cost per test, yet they count different things, so borrowing any of them for a general laboratory cost per test is unsafe without first matching the cost boundary and the test mix. PLOS ONE reports from a provider perspective on suspected tuberculosis patients, which frames cost around what the diagnosing provider incurs for a defined disease pathway rather than the full loaded cost of running a laboratory. NHS England and NHS Improvement instead frame cost across networked NHS laboratories, so its figure reflects consolidated pathology delivered through shared, networked infrastructure, a wider cost envelope than a single provider pathway. Comparing the two means comparing a provider-perspective disease cost against a networked-laboratory operating cost, and they are not the same denominator.
The UK Department of Health source splits further by test complexity. One strand covers complex pathology tests, the other covers routine chemistry and haematology tests, and those two carry very different labour, instrumentation, and reagent profiles. A cost boundary drawn around complex assays cannot be laid over a mix dominated by routine chemistry and haematology without distorting what the number means. Test-complexity mix is therefore its own axis of divergence, separate from whose costs are being counted.
All four are UK-framed and healthcare pathology framed, drawn from England and comparator health systems such as Australia and the USA. That shared framing masks the underlying disagreement: PLOS ONE, NHS England and NHS Improvement, and the UK Department of Health do not agree on which costs are in scope or on which tests populate the denominator. A customer who wants a defensible cost per test should treat these as methodology references, confirm the cost inclusions and the test mix each one assumes, and only then decide whether any of them maps to their own laboratory.
Laboratory Cost per Test works best as a financial guardrail attached to the group's real objectives rather than as an objective of its own. Under the Laboratory Quality Management objective to drive operational excellence by minimizing equipment and system downtime, cost per test serves as a key result that must hold steady or improve while preventive maintenance and uptime work proceeds, confirming that reliability gains are not being bought at a rising unit cost. Frame the key result directionally: keep cost per test flat or trending down as downtime falls, rather than copying any fixed target as a benchmark.
It also ladders to the objective to improve accuracy and reliability of test results to elevate laboratory quality standards. Here cost per test is the counterweight that keeps quality investment honest: as Test Result Reproducibility Rate and Result Accuracy Verification Rate climb, the key result is that cost per test stays within an acceptable band rather than escalating unchecked. Both framings use the group's genuine objectives and treat cost per test as a supporting, directional key result, never as the headline the team optimizes in isolation.
This KPI is associated with the following categories and industries in our KPI database:
KPI Depot takes you from KPI intelligence to finished deliverable. Consultants, strategy teams, FP&A leaders, and analytics teams use it to answer the two hardest questions in performance management, what to measure and what the target should be, and then to produce the scorecard itself.
The difference is intelligence, not just data. Anyone can list metrics. Every KPI in KPI Depot carries 13 practical attributes, from formula and measurement approach to diagnostic questions, risk warnings, and Balanced Scorecard perspective, across 15 corporate functions and 153 industries. And every target you set is grounded in our database of 34,304 source-attributed benchmarks, each detailing metric value, company size, time period, industry, geography, sample size, and source. Benchmark data at this scale is otherwise the domain of research services costing thousands to hundreds of thousands of dollars per year.
When your metrics are selected, KPI Depot finishes the job: export an interactive Strategy Map, a Balanced Scorecard with formulas and tracking columns, or a CSV KPI pack, and go from research to working deliverable in hours instead of weeks.
Formerly the Flevy KPI Library, KPI Depot is trusted by teams at organizations including Accenture, EY, IBM, PepsiCo, Samsung, and Vodafone.
Got a question? Email us at [email protected].
Several factors contribute to this KPI, including labor costs, material expenses, and operational efficiency. Variability in test complexity and volume also plays a significant role in determining overall costs.
Automation and advanced analytics can streamline processes, minimize errors, and enhance forecasting accuracy. Investing in technology often leads to long-term savings and improved operational efficiency.
Yes, benchmarking against industry standards helps identify areas for improvement. Understanding where your lab stands in relation to peers can drive strategic initiatives and enhance performance.
Training staff on efficient practices is crucial for cost control. Well-trained employees are more likely to follow protocols that minimize waste and maximize resource utilization.
Regular reviews, ideally quarterly, are essential for maintaining control over Laboratory Cost per Test. Frequent assessments allow labs to adapt quickly to changes in expenses and operational dynamics.
Not necessarily. Cost reductions can be achieved through efficiency improvements without compromising quality. Focused initiatives can enhance both financial performance and service excellence.
Each KPI in our knowledge base includes 13 attributes.
A clear explanation of what the KPI measures
The typical business insights we expect to gain through the tracking of this KPI
An outline of the approach or process followed to measure this KPI
The standard formula organizations use to calculate this KPI
Insights into how the KPI tends to evolve over time and what trends could indicate positive or negative performance shifts
Questions to ask to better understand your current position is for the KPI and how it can improve
Practical, actionable tips for improving the KPI, which might involve operational changes, strategic shifts, or tactical actions
Recommended charts or graphs that best represent the trends and patterns around the KPI for more effective reporting and decision-making
Potential risks or warnings signs that could indicate underlying issues that require immediate attention
Suggested tools, technologies, and software that can help in tracking and analyzing the KPI more effectively
How the KPI can be integrated with other business systems and processes for holistic strategic performance management
Explanation of how changes in the KPI can impact other KPIs and what kind of changes can be expected
NEW Mapping to a Balanced Scorecard perspective (financial, customer, internal process, learning & growth)